Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
17
×
business sponsored company news
american medical association
anaerobic digestion
articles containing video clips
biodegradable waste management
biodegradation
carecloud
colloids
deals
dosage forms
drug delivery devices
gels
health
health data
histopathology
illinois
infectious causes of cancer
male genital neoplasia
medical and health professional associations in chicago
medical groups
neoplastic and hyperplastic prostate disorders
organizations established in 1847
physical chemistry
prostate cancer
rtt
supraorganizations
What
announces
17
×
company
17
×
press
release
medical
announced
today
technology
augmenix
develops
hydrogels
manufactures
organs
protect
radiotherapy
risk
sells
separate
absorbable
proprietary
hydrogel
spaceoar
cancer
new
prostate
clinical
patients
data
leading
patient
positive
treated
use
american
applications
association
code
cpt
development
device
Language
Current search:
announces
×
company
×
business
×
@venturebeat.com
6 years ago
Surgical Device Maker Xenco Medical Unveils TraumaGPS, the First Trauma Surgery Delivery App for Spinal Implant Systems
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
6 years ago
Protembis Announces Successful First-in-Human Use of Its ProtEmbo® Cerebral Protection System in European Trial
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Kony Announces New EASE Application to Enhance Patient Experience and Satisfaction
@venturebeat.com
6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
6 years ago
TIESRx™ Announces Significant Platform Upgrade
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Seven Bridges Announces Scientific Advisory Board
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@venturebeat.com
8 years ago
Portea Medical Announces US$37.5 Million Series B Funding Led by Accel
@venturebeat.com
8 years ago
Newron Receives Positive Opinion for Orphan Medicinal Product Designation for Sarizotan to Treat Patients with Rett Syndrome from the Committee for Orphan Medicinal Products from the European Medicines Agency
@venturebeat.com
9 years ago
CareCloud takes $25.5M in debt financing to expand medical group data